A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Taiwan table tennis Olympians win WTT mixed doubles title
10/27/2025 11:41 AM - Society
More rain, cooler temperatures forecast for northern Taiwan this week
10/27/2025 10:36 AM - Business
U.S. dollar down in Taipei trading
10/27/2025 10:19 AM - Business
Taiwan shares open higher
10/27/2025 09:09 AM - Society
Taiwan headline news
10/27/2025 08:45 AM